Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Expanding the global prevalence of spinocerebellar ataxia type 42.

Ngo K, Aker M, Petty LE, Chen J, Cavalcanti F, Nelson AB, Hassin-Baer S, Geschwind MD, Perlman S, Italiano D, Laganà A, Cavallaro S, Coppola G, Below JE, Fogel BL.

Neurol Genet. 2018 Apr 5;4(3):e232. doi: 10.1212/NXG.0000000000000232. eCollection 2018 Jun. No abstract available.

2.

Caffeine inhibits angiogenesis in human glioblastoma cells via HIFs modulation.

Maugeri G, D'Amico AG, Rasà DM, Saccone S, Federico C, Magro G, Cavallaro S, D'Agata V.

Anticancer Agents Med Chem. 2018 Feb 9. doi: 10.2174/1871520618666180209151750. [Epub ahead of print]

PMID:
29424319
3.

Genotyping of KRAS Mutational Status by the In-Check Lab-on-Chip Platform.

Guarnaccia M, Iemmolo R, San Biagio F, Alessi E, Cavallaro S.

Sensors (Basel). 2018 Jan 5;18(1). pii: E131. doi: 10.3390/s18010131.

4.

Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.

Apolloni S, Fabbrizio P, Amadio S, Napoli G, Verdile V, Morello G, Iemmolo R, Aronica E, Cavallaro S, Volonté C.

Front Immunol. 2017 Nov 30;8:1689. doi: 10.3389/fimmu.2017.01689. eCollection 2017.

5.

Effect of Push-Up Position on Wrist Joint Pressures in the Intact Wrist and Following Scapholunate Interosseous Ligament Sectioning.

Daly BT, Werner FW, Cavallaro SM, Tucci ER, Harley BJ.

J Hand Surg Am. 2018 Apr;43(4):339-345. doi: 10.1016/j.jhsa.2017.10.019. Epub 2017 Nov 20.

PMID:
29157783
6.

Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.

Morello G, Spampinato AG, Cavallaro S.

Mediators Inflamm. 2017;2017:7070469. doi: 10.1155/2017/7070469. Epub 2017 Sep 7.

7.

Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration.

D'Amico AG, Maugeri G, Rasà DM, Bucolo C, Saccone S, Federico C, Cavallaro S, D'Agata V.

Peptides. 2017 Nov;97:64-69. doi: 10.1016/j.peptides.2017.09.014. Epub 2017 Sep 28.

PMID:
28964802
8.

PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons.

Bonaventura G, Iemmolo R, D'Amico AG, La Cognata V, Costanzo E, Zappia M, D'Agata V, Conforti FL, Aronica E, Cavallaro S.

J Cell Physiol. 2018 Apr;233(4):3343-3351. doi: 10.1002/jcp.26182. Epub 2017 Oct 20.

PMID:
28926110
9.

Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.

Maugeri G, D'Amico AG, Rasà DM, La Cognata V, Saccone S, Federico C, Cavallaro S, D'Agata V.

Toxicol In Vitro. 2017 Oct;44:182-189. doi: 10.1016/j.tiv.2017.07.003. Epub 2017 Jul 6.

PMID:
28689815
10.

Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.

La Cognata V, Maugeri G, D'Amico AG, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Cell Biochem. 2018 Jan;119(1):1062-1073. doi: 10.1002/jcb.26274. Epub 2017 Aug 23.

PMID:
28688199
11.

WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Rasà DM, D'Amico AG, Maugeri G, Cavallaro S, D'Agata V.

J Mol Neurosci. 2017 Jun;62(2):131-141. doi: 10.1007/s12031-017-0930-0. Epub 2017 May 22. Review.

PMID:
28534317
12.

Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes.

Morello G, Spampinato AG, Cavallaro S.

Front Neurol. 2017 Apr 19;8:152. doi: 10.3389/fneur.2017.00152. eCollection 2017.

13.

NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.

D'Amico AG, Maugeri G, Rasà DM, La Cognata V, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Cell Physiol. 2018 Feb;233(2):1120-1128. doi: 10.1002/jcp.25971. Epub 2017 Sep 28.

PMID:
28436035
14.

Miniaturized Real-Time PCR on a Q3 System for Rapid KRAS Genotyping.

Guarnaccia M, Iemmolo R, Petralia S, Conoci S, Cavallaro S.

Sensors (Basel). 2017 Apr 11;17(4). pii: E831. doi: 10.3390/s17040831.

15.

A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.

Caltabiano R, Magro G, Polizzi A, Praticò AD, Ortensi A, D'Orazi V, Panunzi A, Milone P, Maiolino L, Nicita F, Capone GL, Sestini R, Paganini I, Muglia M, Cavallaro S, Lanzafame S, Papi L, Ruggieri M.

Childs Nerv Syst. 2017 Jun;33(6):933-940. doi: 10.1007/s00381-017-3340-2. Epub 2017 Apr 1.

PMID:
28365909
16.

Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.

D'Antoni S, Ranno E, Spatuzza M, Cavallaro S, Catania MV.

Neurotox Res. 2017 Jul;32(1):58-70. doi: 10.1007/s12640-017-9711-3. Epub 2017 Mar 11.

PMID:
28285347
17.

Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.

Morello G, Spampinato AG, Conforti FL, D'Agata V, Cavallaro S.

J Mol Neurosci. 2017 Apr;61(4):563-580. doi: 10.1007/s12031-017-0898-9. Epub 2017 Feb 24.

18.

Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.

Morello G, Guarnaccia M, Spampinato AG, La Cognata V, D'Agata V, Cavallaro S.

Mol Neurobiol. 2018 Feb;55(2):1299-1322. doi: 10.1007/s12035-017-0393-x. Epub 2017 Jan 24. Review.

19.

Caffeine Prevents Blood Retinal Barrier Damage in a Model, In Vitro, of Diabetic Macular Edema.

Maugeri G, D'Amico AG, Rasà DM, La Cognata V, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Cell Biochem. 2017 Aug;118(8):2371-2379. doi: 10.1002/jcb.25899. Epub 2017 Apr 25.

PMID:
28106278
20.

Drug target identification at the crossroad of neuronal apoptosis and survival.

Maino B, Paparone S, Severini C, Ciotti MT, D'agata V, Calissano P, Cavallaro S.

Expert Opin Drug Discov. 2017 Mar;12(3):249-259. doi: 10.1080/17460441.2017.1280023. Epub 2017 Jan 23. Review.

PMID:
28067072
21.

Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.

Gentile G, Ceccarelli M, Micheli L, Tirone F, Cavallaro S.

Front Pharmacol. 2016 Nov 30;7:449. eCollection 2016.

22.

Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats.

D'Amico AG, Maugeri G, Bucolo C, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Mol Neurosci. 2017 Feb;61(2):256-266. doi: 10.1007/s12031-016-0869-6. Epub 2016 Dec 1.

PMID:
27909871
23.

Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.

La Cognata V, Morello G, D'Agata V, Cavallaro S.

Hum Genet. 2017 Jan;136(1):13-37. doi: 10.1007/s00439-016-1749-4. Epub 2016 Nov 28. Review.

24.

Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.

D'Amico AG, Maugeri G, Reitano R, Cavallaro S, D'Agata V.

Protein J. 2016 Oct;35(5):354-362.

PMID:
27601173
25.

Copy Number Variants in Alzheimer's Disease.

Cuccaro D, De Marco EV, Cittadella R, Cavallaro S.

J Alzheimers Dis. 2017;55(1):37-52. Review.

26.

PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.

Maugeri G, D'Amico AG, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Cell Physiol. 2017 May;232(5):1209-1215. doi: 10.1002/jcp.25616. Epub 2016 Sep 30.

PMID:
27661459
27.

A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's disease.

La Cognata V, Morello G, Gentile G, D'Agata V, Criscuolo C, Cavalcanti F, Cavallaro S.

Neurogenetics. 2016 Oct;17(4):233-244. Epub 2016 Sep 17.

28.

Transcriptional landscapes at the intersection of neuronal apoptosis and substance P-induced survival: exploring pathways and drug targets.

Paparone S, Severini C, Ciotti MT, D'Agata V, Calissano P, Cavallaro S.

Cell Death Discov. 2016 Aug 1;2:16050. doi: 10.1038/cddiscovery.2016.50. eCollection 2016.

29.

Child Abuse Syndrome (CAS): A Newly Recognized Distinct Entity.

Parano E, Pappalardo XG, Pavone P, Ruggieri M, Cavallaro S.

Open Neurol J. 2016 Jun 30;10:30-1. doi: 10.2174/1874205X01610010030. eCollection 2016. No abstract available.

30.

VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.

Maugeri G, D'Amico AG, Gagliano C, Saccone S, Federico C, Cavallaro S, D'Agata V.

J Cell Physiol. 2017 May;232(5):1079-1085. doi: 10.1002/jcp.25510. Epub 2016 Sep 21.

PMID:
27486932
31.

Copy number variations and stroke.

Colaianni V, Mazzei R, Cavallaro S.

Neurol Sci. 2016 Dec;37(12):1895-1904. Epub 2016 Jul 8. Review.

32.

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression.

Maugeri G, D'Amico AG, Reitano R, Magro G, Cavallaro S, Salomone S, D'Agata V.

Front Pharmacol. 2016 May 31;7:139. doi: 10.3389/fphar.2016.00139. eCollection 2016.

33.

A neurocutaneous phenotype with paired hypo- and hyperpigmented macules, microcephaly and stunted growth as prominent features.

Pavone P, Praticò AD, Gentile G, Falsaperla R, Iemmolo R, Guarnaccia M, Cavallaro S, Ruggieri M.

Eur J Med Genet. 2016 May;59(5):283-9. doi: 10.1016/j.ejmg.2016.03.002. Epub 2016 Mar 12.

PMID:
26979654
34.

Parkin modulates expression of HIF-1α and HIF-3α during hypoxia in gliobastoma-derived cell lines in vitro.

Maugeri G, D'Amico AG, Reitano R, Saccone S, Federico C, Cavallaro S, D'Agata V.

Cell Tissue Res. 2016 Jun;364(3):465-74. doi: 10.1007/s00441-015-2340-3. Epub 2016 Jan 8.

PMID:
26742768
35.

Cracking the code of neuronal apoptosis and survival.

Cavallaro S.

Cell Death Dis. 2015 Nov 5;6:e1963. doi: 10.1038/cddis.2015.309.

36.

Expression profile of parkin isoforms in human gliomas.

Maugeri G, D'Amico AG, Magro G, Salvatorelli L, Barbagallo GM, Saccone S, Drago F, Cavallaro S, D'Agata V.

Int J Oncol. 2015 Oct;47(4):1282-92. doi: 10.3892/ijo.2015.3105. Epub 2015 Jul 24.

PMID:
26238155
37.

Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.

Morello G, Cavallaro S.

Future Med Chem. 2015;7(10):1335-59. doi: 10.4155/fmc.15.60. Review.

38.

Splicing: is there an alternative contribution to Parkinson's disease?

La Cognata V, D'Agata V, Cavalcanti F, Cavallaro S.

Neurogenetics. 2015 Oct;16(4):245-63. doi: 10.1007/s10048-015-0449-x. Epub 2015 May 16. Review.

39.

Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.

Morello G, Conforti FL, Parenti R, D'Agata V, Cavallaro S.

Curr Med Chem. 2015;22(17):2004-21. Review.

PMID:
25850769
40.

Note: fast neutron efficiency in CR-39 nuclear track detectors.

Cavallaro S.

Rev Sci Instrum. 2015 Mar;86(3):036103. doi: 10.1063/1.4915502.

PMID:
25832287
41.

Igf1 and Pacap rescue cerebellar granule neurons from apoptosis via a common transcriptional program.

Maino B, D'Agata V, Severini C, Ciotti MT, Calissano P, Copani A, Chang YC, DeLisi C, Cavallaro S.

Cell Death Discov. 2015;1. pii: 15029. Epub 2015 Sep 7.

42.

Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex.

Aronica E, Baas F, Iyer A, ten Asbroek AL, Morello G, Cavallaro S.

Neurobiol Dis. 2015 Feb;74:359-76. doi: 10.1016/j.nbd.2014.12.002. Epub 2014 Dec 10.

43.

Genomic analysis of transcriptional changes underlying neuronal apoptosis.

Cavallaro S.

Methods Mol Biol. 2015;1254:141-51. doi: 10.1007/978-1-4939-2152-2_11.

PMID:
25431063
44.

Editorial: Emerging biomarkers for drug development in amyotrophic lateral sclerosis.

Cavallaro S.

Curr Med Chem. 2014;21(31):3507. No abstract available.

PMID:
25245511
45.

The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.

Ruggieri M, Polizzi A, Spalice A, Salpietro V, Caltabiano R, D'Orazi V, Pavone P, Pirrone C, Magro G, Platania N, Cavallaro S, Muglia M, Nicita F.

Clin Genet. 2015 May;87(5):401-10. doi: 10.1111/cge.12498. Epub 2014 Nov 22. Review.

PMID:
25211147
46.

Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.

Scuderi S, La Cognata V, Drago F, Cavallaro S, D'Agata V.

Biomed Res Int. 2014;2014:690796. doi: 10.1155/2014/690796. Epub 2014 Jul 16.

47.

Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

La Cognata V, Iemmolo R, D'Agata V, Scuderi S, Drago F, Zappia M, Cavallaro S.

Curr Genomics. 2014 Jun;15(3):203-16. doi: 10.2174/1389202915666140426003342.

48.

NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.

D'Amico AG, Scuderi S, Maugeri G, Cavallaro S, Drago F, D'Agata V.

J Mol Neurosci. 2014 Nov;54(3):405-13. doi: 10.1007/s12031-014-0335-2. Epub 2014 May 30.

PMID:
24874579
49.

Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide.

Maino B, Ciotti MT, Calissano P, Cavallaro S.

Int J Mol Sci. 2014 Apr 1;15(4):5596-622. doi: 10.3390/ijms15045596.

50.

Is this the real time for genomics?

Guarnaccia M, Gentile G, Alessi E, Schneider C, Petralia S, Cavallaro S.

Genomics. 2014 Feb-Mar;103(2-3):177-82. doi: 10.1016/j.ygeno.2014.02.003. Epub 2014 Feb 19. Review.

Supplemental Content

Loading ...
Support Center